Company intelligence / Profile preview
GRDG Sciences
Winter Haven, Florida, United Statesgrdgsci.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
GRDG Sciences has achieved major milestones in developing universal therapeutic drug platforms, obtaining a valuation exceeding $500M following its initial cancer and infectious disease research phase, but has not yet advanced to clinical trials.
- Therapeutic areas
- OncologyInfectious DiseasesNeurology
- Modalities
- Small moleculePossibly Biologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Destum Partners
Beyond the preview
Go deeper on GRDG Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GRDG Sciences.